Hartmann, Jakob http://orcid.org/0000-0002-1960-8177
Bajaj, Thomas
Otten, Joy
Klengel, Claudia
Ebert, Tim
Gellner, Anne-Kathrin
Junglas, Ellen
Hafner, Kathrin
Anderzhanova, Elmira A.
Tang, Fiona
Missig, Galen
Rexrode, Lindsay
Trussell, Daniel T. http://orcid.org/0009-0006-8547-3828
Li, Katelyn X.
Pöhlmann, Max L.
Mackert, Sarah http://orcid.org/0000-0001-5074-4874
Geiger, Thomas M.
Heinz, Daniel E. http://orcid.org/0000-0001-7103-9621
Lardenoije, Roy
Dedic, Nina
McCullough, Kenneth M. http://orcid.org/0000-0003-4908-2302
Próchnicki, Tomasz
Rhomberg, Thomas http://orcid.org/0000-0002-4382-999X
Martinelli, Silvia http://orcid.org/0000-0002-8784-2213
Payton, Antony http://orcid.org/0000-0003-0335-152X
Robinson, Andrew C. http://orcid.org/0000-0003-2208-7728
Stein, Valentin http://orcid.org/0000-0003-1222-4928
Latz, Eicke http://orcid.org/0000-0003-1488-5666
Carlezon, William A. Jr
Hausch, Felix
Schmidt, Mathias V. http://orcid.org/0000-0002-3788-2268
Murgatroyd, Chris http://orcid.org/0000-0002-6885-7794
Berretta, Sabina
Klengel, Torsten http://orcid.org/0000-0001-7045-9229
Pantazopoulos, Harry
Ressler, Kerry J. http://orcid.org/0000-0002-5158-1103
Gassen, Nils C. http://orcid.org/0000-0002-4265-3398
Article History
Received: 12 January 2023
Accepted: 15 March 2024
First Online: 25 March 2024
Competing interests
: N.D. is currently an employee of Sumitomo Pharma America. K.M.M. is currently an employee of Jazz Pharmaceuticals. S.M. is currently an employee of Roche Diagnostics. Their contributions pre-date that employment and their co-authorship do not reflect collaboration on this project with these organizations. K.J.R. has received consulting income from Alkermes, Bionomics, and BioXcel and is on scientific advisory boards for Janssen and Verily for unrelated work. He has also received a sponsored research grant support from Takeda, Alto Neuroscience, and Brainsway for unrelated work. T.K. has received consulting income from Alkermes for unrelated work. Within the last 2 years, W.A.C. has served as a consultant for Psy Therapeutics and has had sponsored research agreements with Cerevel Therapeutics and Delix Therapeutics. The remaining authors declare no competing interests.